Skip to content

Clinical trials

Phase 2 Insulinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulinoma Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20042
20051
20071
20081
20101
20121
20131
20142
20161
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
ECOG-ACRIN Cancer Research Group2
Delcath Systems Inc.1
Eastern Cooperative Oncology Group1
Emory University1
Masonic Cancer Center, University of Minnesota1
Memorial Sloan Kettering Cancer Center1
Ohio State University Comprehensive Cancer Center1
Shaheen Shagufta1
University of Southern California1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulinoma16
Glucagonoma15
Somatostatinoma15
Carcinoma, Islet Cell12
Gastrinoma12
Vipoma6
Adenoma, Islet Cell5
Neoplasms4
Pancreatic Neoplasms3
Carcinoma, Medullary2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.